Literature DB >> 2509094

c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor.

M Caggana1, A R Kennedy.   

Abstract

We have studied whether the Bowman-Birk protease inhibitor (BBI) could affect the expression of c-fos in BALB/c/3T3 cells stimulated to divide with serum. Our results show that the levels of c-fos message are significantly decreased in the presence of antipain and BBI. When the cells were treated with cycloheximide after being grown in the presence of BBI, there was no significant decrease in mRNA levels. Our experiments suggest that a BBI-inhibitable protease may be necessary for c-fos expression in 3T3 cells and that new protein synthesis is required for this hypothesized protease to be active. As BBI is capable of affecting c-fos gene expression in cells without being present in the nucleus, our results suggest that a novel pathway could be involved in c-fos gene expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509094     DOI: 10.1093/carcin/10.11.2145

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

Review 1.  Is there a critical target gene for the first step in carcinogenesis?

Authors:  A R Kennedy
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

Review 2.  Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications.

Authors:  Agata Gitlin-Domagalska; Aleksandra Maciejewska; Dawid Dębowski
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-25

3.  A serine protease-inhibitory benzamidine derivative inhibits the growth of human colon carcinoma cells.

Authors:  Y Nishimura; W Yasui; K Yoshida; T Matsuyama; K Dohi; E Tahara
Journal:  Jpn J Cancer Res       Date:  1992-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.